THE MISSION

Leading the push for vertically integrated US injectable manufacturing

63% of All Drug Shortages are Injectables.1

 

There are many reasons pharmaceutical drug shortages occur. Unfortunately, drug shortages disproportionally affect the injectables market where hospitals need these drugs to treat the most critical patients. These factors, combined with decades of injectables production being sent offshore to India, China and others, have left us with significant domestic injectable supply problems. Quality and reliability are at all-time lows for these essential medicines.

AMERICAN INJECTABLES PROVIDES IMMEDIATE SOLUTIONS

American Injectables addresses these current challenges with US-based manufacturing, advanced technology, and vertical integration to re-shore our injectables supply chain, improve product quality, and create dependable supply.

US FACILITY

New state-of-the-art facility for flexible injectable manufacturing ready to begin production now

PRODUCT DEVELOPMENT

Five essential medicines available in 2022 and more on the way

VERTICAL INTEGRATION

Integrating supply from starting materials all the way to finished dosage forms (vials, syringes, etc.)